PITTSBURGH, Nov. 25, 2013 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product. The product is a biosimilar to Roche’s Herceptin®, indicated for the treatment […]
LAVAL, Quebec, Nov. 25, 2013 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Dr. Ari Kellen has been named to Valeant’s Executive Management Team and will assume the role of Executive Vice President/Company Group Chairman, effective January 1, 2014. Dr. Ari Kellen was a senior partner in McKinsey & […]
NEW YORK & BUDAPEST, Hungary– November 21, 2013 — (BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) and Gedeon Richter Plc. announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for cariprazine, an atypical antipsychotic for the treatment of schizophrenia and for the acute treatment of manic or […]
RICHMOND, Calif., Nov. 20, 2013 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that seven abstracts have been accepted for presentation at the 55TH annual meeting of the American Society of Hematology (ASH), which will be heldDecember 7-10, 2013, in New Orleans, LA. “ASH provides an outstanding forum to highlight our advancing pre-clinical IND-candidate programs,” said Edward Lanphier, Sangamo’s president and CEO. “In particular, […]
Doral Pulley, Ph.D., lost his wife, Alecia, 11 days after giving birth to twin daughters. Twenty years later, her family still misses her. SOURCE: Merck
STOCKHOLM, November 19 – Yonsei University Health System (YUHS) has reinforced its commitment to Elekta’s radiation therapy systems with the recent order of four additional high-end Elekta linear accelerators. The four linear accelerators, representing an order value of approximately USD 10 million, were booked in the second quarter of fiscal year 2013/14. “These systems provide […]
New sponsorship of “Red Riders®”–cyclists with diabetes–added in 5 cities INDIANAPOLIS, Nov. 19, 2013 /PRNewswire/ — News Highlights: For a 2nd year, #Lilly #Diabetes supports the American Diabetes Association’s Tour de Cure cycling event to help #StopDiabetes New in 2014, #Lilly #Diabetes to support #RedRider cyclists with #diabetes in 5 cities Lilly Tour de Cure […]
Largest Prospective, Multi-Year, Physician-Led Registry Advances Understanding of Real-World Satisfaction with Penile Prostheses MINNEAPOLIS, Nov. 19, 2013 /PRNewswire/ — American Medical Systems® (AMS), Inc. an Endo Health Solutions Inc. (Nasdaq: ENDP) subsidiary and leading provider of devices and therapies for male and female pelvic health, today announced the enrollment of the 500th patient in the largest multi-year, prospective global […]
PALO ALTO, Calif., Nov. 18, 2013 /PRNewswire/ — Varian Medical Systems, Inc. (NYSE:VAR) today announced that Regina E. Dugan, Ph.D., Senior Vice President of Advanced Technology and Projects (ATAP) at Google’s Motorola Mobility LLC, has been appointed to the Varian Board of Directors, effective December 15, 2013. “We believe that Regina is eminently qualified to serve as a director […]
– Company awarded 180 days marketing exclusivity – PITTSBURGH, Nov. 18, 2013 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Dexmethylphenidate Hydrochloride Extended-release (ER) Capsules, 30 mg, which is the first generic version of Novartis’ Focalin XR®. Mylan was the first company to have filed a substantially […]